시장보고서
상품코드
1779214

세계의 소화성 디아민 산화효소 보충제 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 용도별, 지역별, 경쟁(2020-2030년)

Digestive Diamine Oxidase Enzyme For Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 186 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 소화성 디아민 산화효소 보충제 시장은 2024년에 2,129만 달러로 평가되었고, 예측 기간 3,013만 달러에 이를 전망이며, 2030년까지 연평균 복합 성장률(CAGR) 5.92%로 성장이 예측되고 있습니다.

소화성 디아민 산화효소 보충제 생산의 확대는 자연적인 치료에 대한 동경 증가와 함께 히스타민 불내성 사례 증가에 의해 추진되고 있습니다. 게다가 온라인 판매에 의한 소화성 디아민 산화효소 보충제에 대한 접근의 증가가 시장의 수요를 끌어올릴 것으로 예상됩니다.

시장 개요
예측 기간 2026-2030년
시장 규모(2024년) 2,129만 달러
시장 규모(2030년) 3,013만 달러
CAGR(2025-2030년) 5.92%
급성장 부문 캡슐
최대 시장 북미

시장 성장 촉진요인

식품 불내성에 대한 의식 증가

제한적인 인지

주요 시장 동향

조사 및 임상 연구 증가

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 소화성 디아민 산화효소 보충제 시장 전망

  • 시장 규모 및 예측
    • 금액별
  • 시장 점유율 및 예측
    • 유형별(캡슐, 정제)
    • 용도별(병원, 재택 케어, 전문 클리닉)
    • 지역별
    • 기업별(2024년)
  • 제품 시장 맵
    • 유형별
    • 용도별
    • 지역별

제6장 북미의 소화성 디아민 산화효소 보충제 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 소화성 디아민 산화효소 보충제 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 유럽 : 국가별 분석
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인

제8장 아시아태평양의 소화성 디아민 산화효소 보충제 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국

제9장 남미의 소화성 디아민 산화효소 보충제 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 소화성 디아민 산화효소 보충제 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율 및 예측
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향 및 발전

  • 최근 동향
  • 합병 및 인수
  • 제품 출시

제13장 Porter's Five Forces 분석

  • 업계 내 경쟁
  • 신규 진입의 가능성
  • 공급자의 힘
  • 고객의 힘
  • 대체품의 위협

제14장 경쟁 구도

  • Seeking Health, LLC
  • Eat All(Stada Group)
  • Pure Encapsulations Inc
  • Enzymedica Inc
  • Swanson Health Products Inc
  • Xymogen Inc

제15장 전략적 제안

제16장 기업 소개 및 면책사항

AJY 25.08.04

Global Digestive Diamine Oxidase Enzyme For Supplements Market was valued at USD 21.29 Million in 2024 and is expected to reach USD 30.13 Million in the forecast period with a CAGR of 5.92% through 2030. The expansion of DAO enzyme production for dietary supplements is propelled by the increasing instances of histamine intolerance, along with a growing fascination with natural remedies. Additionally, the increasing accessibility of digestive diamine oxidase supplements through online sellers is expected to boost market demand.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 21.29 Million
Market Size 2030USD 30.13 Million
CAGR 2025-20305.92%
Fastest Growing SegmentCapsules
Largest MarketNorth America

Key Market Drivers

Increasing Awareness of Food Intolerances

Food intolerance has become a pervasive health concern worldwide, affecting millions of individuals who experience discomfort and digestive distress after consuming certain foods. Fortunately, increasing awareness of these intolerances is not only promoting healthier eating habits but also driving the growth of the global Digestive Diamine Oxidase (DAO) enzyme for supplements market. Food intolerances refer to adverse reactions to specific foods or components of food, which do not involve the immune system. Unlike food allergies, which can be life-threatening, intolerances typically result in milder symptoms like bloating, gas, abdominal pain, diarrhea, or skin rashes. Common food intolerances include lactose intolerance (inability to digest lactose, found in dairy products), gluten intolerance (non-celiac gluten sensitivity), and histamine intolerance (difficulty breaking down histamine-rich foods). As people become more educated about food intolerance, they are better equipped to recognize the symptoms they may be experiencing. This self-awareness encourages individuals to seek solutions to alleviate their discomfort, driving them towards supplements like DAO enzymes that can help manage these symptoms effectively. The internet and social media have made it easier for individuals to access information about food intolerances. Many people are now engaging in self-diagnosis or seeking advice from healthcare professionals based on their symptoms. This has resulted in a growing demand for over-the-counter supplements as a first-line approach to managing intolerance-related issues. The modern focus on health and wellness has led individuals to take a more proactive approach to their well-being. People are increasingly interested in understanding their bodies and how their diets affect their health. This shift in mindset has created a receptive market for supplements that can help manage food intolerances. A significant proportion of individuals with food intolerances have chosen to modify their diets to avoid trigger foods. However, complete avoidance can be challenging, and many still seek ways to enjoy their favorite foods without discomfort. DAO enzyme supplements offer an attractive option for occasional indulgence without suffering the consequences. Awareness of food intolerance has also increased among healthcare professionals. Doctors and dietitians are more likely to diagnose and recommend solutions for these conditions, including DAO enzyme supplements, as part of a comprehensive treatment plan.

Limited Awareness

One of the major challenges facing the Digestive Diamine Oxidase (DAO) Enzyme for Supplements Market is limited awareness among both consumers and healthcare professionals. Despite growing interest in digestive health, histamine intolerance remains underdiagnosed and misunderstood. According to a 2023 survey published in the World Journal of Gastroenterology, less than 10% of general practitioners are familiar with DAO deficiency as a contributing factor to chronic gastrointestinal symptoms. As a result, many individuals with histamine intolerance continue to experience symptoms such as headaches, bloating, and skin rashes without receiving appropriate guidance or treatment.

In parallel, consumer awareness is also low. A 2023 survey conducted across North America and Europe found that only 12% of respondents had heard of DAO supplements or understood their purpose in managing histamine-related digestive issues. This lack of knowledge slows down market penetration and restricts growth potential, especially in emerging economies where education around nutraceuticals is still developing.

Key Market Trends

Increased Research and Clinical Studies

The Digestive Diamine Oxidase (DAO) Enzyme for Supplements Market is experiencing a notable rise in research and clinical studies, driven by increasing awareness of histamine intolerance and its impact on digestive health. Consumers are becoming more proactive in addressing gastrointestinal issues linked to histamine buildup, which has led to growing demand for enzyme-based solutions like DAO. To meet this demand and establish credibility, manufacturers are prioritizing scientific validation through rigorous research efforts.

As of November 2024, more than 515,000 clinical trials have been registered globally-a significant increase that highlights the broader trend toward evidence-based development in the nutraceutical and dietary supplement space. This surge in trials reflects the market's commitment to understanding the efficacy, safety, and long-term benefits of DAO supplementation. Research is particularly focused on how DAO enzymes can help degrade excess histamine in the gut, thereby alleviating symptoms such as bloating, headaches, and skin reactions.

Moreover, ongoing studies are also exploring the bioavailability, dosage optimization, and synergistic effects of DAO when combined with other gut-health-supporting ingredients. This expanding scientific base is expected to not only drive product innovation but also enhance consumer confidence and support regulatory approvals, ultimately strengthening the global position of DAO supplements in digestive health management.

Key Market Players

  • Seeking Health, LLC
  • Eat All (Stada Group)
  • Pure Encapsulations Inc
  • Enzymedica Inc
  • Swanson Health Products Inc
  • Xymogen Inc

Report Scope:

In this report, the Global Digestive Diamine Oxidase Enzyme For Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digestive Diamine Oxidase Enzyme For Supplements Market, By Type:

  • Capsules
  • Tablets

Digestive Diamine Oxidase Enzyme For Supplements Market, By Application:

  • Hospitals
  • Homecare
  • Specialty Clinics

Digestive Diamine Oxidase Enzyme For Supplements Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digestive Diamine Oxidase Enzyme For Supplements Market.

Available Customizations:

Global Digestive Diamine Oxidase Enzyme For Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digestive Diamine Oxidase Enzyme For Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Capsules, Tablets)
    • 5.2.2. By Application (Hospitals, Homecare, Specialty Clinics)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Type
    • 5.3.2. By Application
    • 5.3.3. By Region

6. North America Digestive Diamine Oxidase Enzyme For Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Capsules, Tablets)
    • 6.2.2. By Application (Hospitals, Homecare, Specialty Clinics)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Digestive Diamine Oxidase Enzyme For Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Capsules, Tablets)
    • 7.2.2. By Application (Hospitals, Homecare, Specialty Clinics)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. France Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Digestive Diamine Oxidase Enzyme For Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Capsules, Tablets)
    • 8.2.2. By Application (Hospitals, Homecare, Specialty Clinics)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. Japan Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. India Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. Australia Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. South Korea Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Digestive Diamine Oxidase Enzyme For Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Capsules, Tablets)
    • 9.2.2. By Application (Hospitals, Homecare, Specialty Clinics)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Digestive Diamine Oxidase Enzyme For Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Capsules, Tablets)
    • 10.2.2. By Application (Hospitals, Homecare, Specialty Clinics)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
    • 10.3.4. Kuwait Digestive Diamine Oxidase Enzyme For Supplements Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Type
        • 10.3.4.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Seeking Health, LLC
    • 14.1.1. Business Overview
    • 14.1.2. Product Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Key Personnel
  • 14.2. Eat All (Stada Group)
  • 14.3. Pure Encapsulations Inc
  • 14.4. Enzymedica Inc
  • 14.5. Swanson Health Products Inc
  • 14.6. Xymogen Inc

15. Strategic Recommendations

16. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제